SAND POINT, Idaho--(BUSINESS WIRE)--Today, Percussionaire Corporation, Adel Bougatef, MD PhD, and Marleen De Heyn announced that a confidential settlement was reached between all parties in the litigation regarding Dr. Bougatef’s departure from his role as President of the company in the Fall of 2013.
“We thank Dr. Bougatef for his past service at Percussionaire and for his commitment to Intrapulmonary Percussive Ventilation (IPV) and its application to patients worldwide,” said Cathy Bird Natoni, the President of and Chairman of the Board for Percussionaire. “We are pleased to put this lawsuit behind us and we wish Dr. Bougatef the best in his future endeavors.”
“We are happy to have reached a resolution in this matter and we respect Percussionaire’s technology,” said Dr. Bougatef and Marleen De Heyn. “We wish Percussionaire the best going forward.”
The settlement terms were not disclosed, but the parties regard the agreement as equitable and respectful. Both parties share the view that patients suffering from devastating respiratory conditions are their top priority; and both will continue to promote IPV use for patients in need.